• Please log in or register to access this feature.

Correspondence

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation †‡

Analysis of trends over time

  1. Ian E. Haines MBBS, FRACP, FAChPM1,2

Article first published online: 23 OCT 2012

DOI: 10.1002/cncr.27876

Issue

Cancer

Cancer

Volume 119, Issue 5, page 1113, 1 March 2013

Additional Information

How to Cite

Haines, I. E. (2013), Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation . Cancer, 119: 1113. doi: 10.1002/cncr.27876

Author Information

  1. 1

    Department of Medicine, Monash University, Malvern, Victoria, Australia

  2. 2

    Medical Oncology and Palliative Care, Melbourne Oncology Group, Cabrini Health, Melbourne, Victoria, Australia

  1. †

    See related article:Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation

  2. ‡

    See related article:Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation

Publication History

  1. Issue published online: 19 FEB 2013
  2. Article first published online: 23 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (47K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (47K)